Article Details

Can-Fite BioPharma Shares Jump 80% on Complete Response for Namodenoson - MarketWatch

Retrieved on: 2021-12-20 16:08:44

Tags for this article:

Click the tags to see associated articles and topics

Can-Fite BioPharma Shares Jump 80% on Complete Response for Namodenoson - MarketWatch. View article details on hiswai:

Excerpt

By Chris Wack Can-Fite BioPharma Ltd. shares were up 80%, to $2.29, in early trade after the company said the last patient treated under an Open ...

Article found on: www.marketwatch.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up